Document is current
Any future updates will be listed below
-
Authors
Weinert, Tobias
Olieric, Natacha
Cheng, Robert
Brünle, Steffen
James, Daniel
Ozerov, Dmitry
Gashi, Dardan
Vera, Laura
Marsh, May
Jaeger, Kathrin
Dworkowski, Florian
Panepucci, Ezequiel
Basu, Shibom
Skopintsev, Petr
Doré, Andrew S.
Geng, Tian
Cooke, Robert M.
Liang, Mengning
Prota, Andrea E.
Panneels, Valerie
Nogly, Przemyslaw https://orcid.org/0000-0002-8040-7753
Ermler, Ulrich
Schertler, Gebhard
Hennig, Michael
Steinmetz, Michel O.
Wang, Meitian
Standfuss, Jörg
- License Information
-
More Information
Article History
Received: 30 March 2017
Accepted: 14 July 2017
First Online: 14 September 2017
Competing interests
: M.H. and G.S. are co-founders of leadXpro AG, a company exploring serial crystallography for structure based drug design. R.C. is an employee of leadXpro AG. A.D., T.G. and R.M.C. are employees of Heptares, a drug discovery and development company working in the field of G-protein-coupled receptor structure-based drug design. The remaining authors declare no competing financial interests.
